Intramuscular versus intradermal administration of fractional dose inactivated poliovirus vaccine in Mozambique, 2020–2022: an, open-label, non-inferiority, randomised, controlled phase 2 trial
Authors
- Rocio Lopez Cavestany (ORCID: https://orcid.org/0000-0003-3424-4030)
- Bernardo A. Mainou (ORCID: https://orcid.org/0000-0002-7721-183X)
- Ilesh Vinodrai Jani (ORCID: https://orcid.org/0000-0002-6880-6655)
- Ondrej Mach (ORCID: https://orcid.org/0000-0001-9100-8312)
- Catildo Cubai (ORCID: https://orcid.org/0009-0004-5887-9174)
- Kassia Pereira (ORCID: https://orcid.org/0000-0003-4379-2805)
- Edna Viegas (ORCID: https://orcid.org/0000-0003-4691-9920)
- Visalakshi Jeyaseelan
- Sandra Valdez
- Emilia Fumane (ORCID: https://orcid.org/0009-0009-4963-7962)
- Mahira Amade (ORCID: https://orcid.org/0009-0002-6966-4465)
- Onélia Guilche
Institutions
- Centers for Disease Control and Prevention (US)
- World Health Organization (CH)
- Instituto Nacional de Saúde (MZ)